EPHA3 and neoplasm: Our results thus indicate an important functional role of EphA3 in mesenchymal CAF-like cells recruited to tumours that promote angiogenesis and tumour growth, and suggest the potential of EphA3 as a therapeutic target in the TME of solid tumours.